GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
V

Vivos Therapeutics VVOS · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.10

+2.24%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Vivos Therapeutics

From its filings with the US Securities and Exchange Commission

SEC filings

Vivos Therapeutics is based in Littleton, Colorado and is incorporated in Delaware. Its shares trade on Nasdaq under the ticker VVOS. The SEC classifies its business as surgical & medical instruments & apparatus. In the fiscal year to 31 December 2025, it reported revenue of $17.4m and a net loss of $21.2m. At that date it held total assets of $25.2m and shareholders' equity of −$1.5m.

Read the filing on SEC.gov ↗

Company facts

Sector
Health Care
Industry
Health Care Providers & Services
Listed since
11 Dec 2020
Employees
154
Website
vivos.com ↗
Head office
7921 SOUTHPARK PLAZA,, LITTLETON, CO, 80120
Incorporated in
DE
Classification
Surgical & Medical Instruments & Apparatus
Filer status
Non-accelerated filer<br>Smaller reporting company

Leadership

Pay as last reported

  • Mr. R. Kirk HuntsmanChairman of the Board, Chief Executive Officer, Co-Founder, since 2016$1.3m
  • Mr. Bradford AmmanChief Financial Officer$706,778
  • Dr. Ralph GreenIndependent Director$65,840
  • Ms. Anja KrammerIndependent Director$65,840
  • Mr. Mark LindsayIndependent Director$65,840
  • Mr. Leonard SokolowIndependent Director$70,840
  • Dr. Matthew ThompsonIndependent Director$70,840

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Vivos Therapeutics Inc employs 154 full-time employees in the Health Care sector.
  • The Vivos Method offers non-invasive, non-surgical treatment for mild to moderate OSA and snoring.
  • The Vivos Integrated Practice program trains dentists to use the Vivos System effectively.

Weaknesses

  • Vivos Therapeutics Inc is a US-based company with headquarters in Littleton, Colorado.
  • The company's IPO occurred on 11 December 2020, limiting recent market exposure.
  • Vivos Therapeutics operates within the Health Care Providers & Services industry segment.

Opportunities

  • The Vivos Method targets patients with cranial and dentofacial abnormalities in the US market.
  • The Vivos Integrated Practice program expands dentists' services for OSA and snoring treatments.
  • Vivos Complete Airway Repositioning and Expansion (CARE) oral appliance therapy has growing demand.

Threats

  • Vivos Therapeutics Inc faces competition in the Health Care Providers & Services industry.
  • The company's focus on mild to moderate OSA may limit market size compared to severe cases.
  • The Health Care sector requires strict regulatory approvals for new treatments.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.